Selective allergic reactions to clavulanic acid: a report of 9 cases.

@article{SnchezMorillas2010SelectiveAR,
  title={Selective allergic reactions to clavulanic acid: a report of 9 cases.},
  author={Leticia S{\'a}nchez-Morillas and Patricia Rojas P{\'e}rez-Ezquerra and Mar Rea{\~n}o-Martos and Jos{\'e} Julio Laguna-Mart{\'i}nez and Maria Luisa Nueda Sanz and Lorena Morales Mart{\'i}nez},
  journal={The Journal of allergy and clinical immunology},
  year={2010},
  volume={126 1},
  pages={177-9}
}
Supported by GlaxoSmithKline, Greenford, United Kingdom, and the Swiss National Science Foundation (grant No. 310030_129640/1). The trial was conducted under GlaxoSmithKline protocol no. MEE103226 (ClinicalTrials.gov identifier: NCT00274703). Disclosure of potential conflict of interest: A. Straumann has received research support from GlaxoSmithKline. H.-U. Simon has received research support from GlaxoSmithKline, AstraZeneca, Roche, CSL Behring, and Nycomed and has provided legal consultation… CONTINUE READING